These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19716455)

  • 1. Control of RANKL gene expression.
    O'Brien CA
    Bone; 2010 Apr; 46(4):911-9. PubMed ID: 19716455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Wnt signals in bone resorption during physiological and pathological states.
    Maeda K; Takahashi N; Kobayashi Y
    J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.
    Yang Y; Blair HC; Shapiro IM; Wang B
    J Biol Chem; 2015 Jul; 290(27):16918-28. PubMed ID: 25979341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminothiazoles inhibit osteoclastogenesis and PGE
    Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.
    Fujiwara Y; Piemontese M; Liu Y; Thostenson JD; Xiong J; O'Brien CA
    J Biol Chem; 2016 Nov; 291(48):24838-24850. PubMed ID: 27733688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
    Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
    Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.
    Vinik Y; Shatz-Azoulay H; Vivanti A; Hever N; Levy Y; Karmona R; Brumfeld V; Baraghithy S; Attar-Lamdar M; Boura-Halfon S; Bab I; Zick Y
    Elife; 2015 May; 4():e05914. PubMed ID: 25955862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue.
    Ogasawara T; Yoshimine Y; Kiyoshima T; Kobayashi I; Matsuo K; Akamine A; Sakai H
    J Periodontal Res; 2004 Feb; 39(1):42-9. PubMed ID: 14687227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms involved in normal and pathological osteoclastogenesis.
    Park-Min KH
    Cell Mol Life Sci; 2018 Jul; 75(14):2519-2528. PubMed ID: 29670999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-embedded cells control osteoclast formation.
    Xiong J; Onal M; Jilka RL; Weinstein RS; Manolagas SC; O'Brien CA
    Nat Med; 2011 Sep; 17(10):1235-41. PubMed ID: 21909103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
    Dela Cruz A; Grynpas MD; Mitchell J
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.
    Xu S; Zhang Y; Liu B; Li K; Huang B; Yan B; Zhang Z; Liang K; Jia C; Lin J; Zeng C; Cai D; Jin D; Jiang Y; Bai X
    J Bone Miner Res; 2016 Jul; 31(7):1320-33. PubMed ID: 26825871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation.
    Souza PPC; Lerner UH
    Front Immunol; 2019; 10():1663. PubMed ID: 31379855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
    Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
    Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.